2-(4-methoxyphenyl)-2-oxoacetamide | 935764-11-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-methoxyphenyl)-2-oxoacetamide
• CAS: 935764-11-7
• 化学式: C₉H₉NO₃
• mdl: MFCD20547535
• 分子量: 179.175
• InChiKey: RRGRRYUKOPKINT-UHFFFAOYSA-N

物化性质

• 熔点：
  148-149 °C
• 沸点：
  352.7±44.0 °C(Predicted)
• 密度：
  1.229±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  69.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-methoxyphenyl)-2-oxoacetamide 在 乙醚 作用下， 生成 2-羟基-2-(4-甲氧基苯基)丙酸
  参考文献：
  名称：

  McKenzie; Ritchie, Biochemische Zeitschrift, 1932, vol. 250, p. 376,383

  摘要：

  DOI：
• 作为产物：
  描述：

  对甲氧基苯乙醛酸 在 氨 、 乙酰氯 作用下， 以 甲醇 为溶剂， 反应 8.0h， 生成 2-(4-methoxyphenyl)-2-oxoacetamide
  参考文献：
  名称：

  Biocatalytic reduction of α-keto amides to (R)-α-hydroxy amides using Candida parapsilosis ATCC 7330

  摘要：

  Biocatalytic reduction of primary and secondary alpha-keto amides was accomplished using whole cells of Candida parapsilosis ATCC 7330. The primary (R)-alpha-hydroxy amides were obtained in good enantiomeric excess (up to 94%) and conversion (88-99%) as compared to the secondary (R)-alpha-hydroxy amides. (C) 2012 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.cattod.2012.03.081

文献信息

• [EN] SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS<br/>[FR] COMPOSÉS DE TRIAZOLE ET D'IMIDAZOLE SUBSTITUÉS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014086663A1

  公开（公告）日：2014-06-12

  The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are LMP7 inhibitors and may be useful in treating associated inflammatory diseases and disorders such as, for example, rheumatoid arthritis, lupus and irritable bowel disease.

  这项发明涉及式(I)的化合物及其药用可接受的盐。此外，本发明涉及制造和使用式(I)的化合物的方法，以及含有这种化合物的药物组合物。式(I)的化合物是LMP7抑制剂，可能在治疗相关的炎症性疾病和紊乱方面有用，例如类风湿性关节炎、红斑狼疮和肠易激综合征。
• Indolinone derivatives as protein kinase/phosphatase inhibitors
  申请人：——

  公开号：US20020052369A1

  公开（公告）日：2002-05-02

  The present invention relates to certain 2-indolinone compounds which modulate the activity of protein kinases (“PKs”) and phosphatases. The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

  本发明涉及调节蛋白激酶（“PKs”）和磷酸酶活性的某些2-吲哚酮化合物。因此，本发明的化合物在治疗与异常PK活性相关的疾病方面是有用的。还公开了包含这些化合物的药物组合物、利用包含这些化合物的药物组合物治疗疾病的方法以及制备它们的方法。
• Metabolically stable vanillin derivatives for the treatment of hypoxia
  申请人：King Abdulaziz University

  公开号：US11104632B1

  公开（公告）日：2021-08-31

  Vanillin derivative compounds that bind covalently with hemoglobin are provided. Methods of treating sickle cell disease and other hypoxia-related disorders by administering such compounds are also provided.

  提供了与血红蛋白共价结合的香草醛衍生物化合物。还提供了通过给予这些化合物来治疗镰状细胞病和其他缺氧相关疾病的方法。
• [EN] SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)<br/>[FR] PYRIDONES SUBSTITUES INHIBITEURS DE LA POLY(ADP-RIBOSE) POLYMERASE (PARP)
  申请人：AVENTIS PHARMA INC

  公开号：WO2005097750A1

  公开（公告）日：2005-10-20

  The present invention discloses and claims a series of 2,3,5-substituted pyridone derivatives as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5'-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.

  本发明公开并声明了一系列如下定义的2,3,5-取代吡啶酮衍生物。本发明还涉及制备这些化合物的方法。本发明的化合物是多聚腺苷酸二磷酸核糖酶（PARP）的抑制剂，因此在制药剂中特别用于治疗和/或预防各种疾病，包括与中枢神经系统和心血管疾病相关的疾病。
• Facile synthesis of primary amides and ketoamides via a palladium-catalysed carbonylation–deprotection reaction sequence
  作者：Eszter Takács、Csilla Varga、Rita Skoda-Földes、László Kollár

  DOI：10.1016/j.tetlet.2007.02.043

  日期：2007.4

  Various primary amides and ketoamides have been obtained in good yields in a two-step reaction sequence. The first step involves the synthesis of aryl/alkenyl N-tert-butyl amides and aryl N-tert-butyl ketoamides from the corresponding iodides via palladium-catalysed carbonylation in the presence of t-BuNH2 as the nucleophile. Carbonylation was followed by selective cleavage of the t-Bu group using

  在两步反应序列中，已经以高收率获得了各种伯酰胺和酮酰胺。第一个步骤涉及的芳基/烯合成Ñ -叔丁基酰胺和芳基ñ -叔丁基酮酰胺从通过在存在钯催化的羰基的相应的碘化物吨-BuNH 2作为亲核试剂。羰基化之后，使用TBDMSOTf作为试剂选择性切割t- Bu基团。